Title: NICE issues supplementary advice for appraising end-of-life drugs which exceed £30,000 per QALY
Author: National Institute for Clinical Excellence (NICE)
Year of publication: 2009
In a nutshell: NICE has issued supplementary advice for its Appraisal Committees, to be considered when they are appraising treatments which may be life-extending for patients with short life expectancy, and which are licensed for indications affecting small numbers of patients with incurable illnesses. This advice forms an addendum to section 6.2.25 of the Guide to the Methods of Technology Appraisal.
Length of publication: 3 pages.